4//SEC Filing
McCourt Marion 4
Accession 0001968202-24-000125
CIK 0000872589other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:01 PM ET
Size
9.1 KB
Accession
0001968202-24-000125
Insider Transaction Report
Form 4
McCourt Marion
SVP Commercial
Transactions
- Sale
Common Stock
2024-09-03$1178.73/sh−1,000$1,178,730→ 12,931 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-09-03−1,000→ 8,000 totalExercise: $381.40Exp: 2028-12-12→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2024-09-03$381.40/sh+1,000$381,400→ 13,931 total
Holdings
- 174(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001663758
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:01 PM ET
- Size
- 9.1 KB